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Abstract
Belle (Bel), the Drosophila homolog of the yeast DEAD-box RNA helicase DED1 and human 
DDX3, has been shown to be required for oogenesis and female fertility. Here we report a novel 
role of Bel in regulating the expression of transgenes. Abrogation of Bel by mutations or RNAi 
induces silencing of a variety of P-element-derived transgenes. This silencing effect depends on 
downregulation of their RNA levels. Our genetic studies have revealed that the RNA helicase 
Spindle-E (Spn-E), a nuage RNA helicase that plays a crucial role in regulating RNA processing 
and PIWI-interacting RNA (piRNA) biogenesis in germline cells, is required for loss-of-bel-
induced transgene silencing. Conversely, Bel abrogation alleviates the nuage-protein 
mislocalization phenotype in spn-E mutants, suggesting a competitive relationship between these 
two RNA helicases. Additionally, disruption of the chromatin remodeling factor Mod(mdg4) or the 
microRNA biogenesis enzyme Dcr-1 also rescued the transgene-silencing phenotypes in bel 
mutants, suggesting the involvement of chromatin remodeling and microRNA biogenesis in loss-
of-bel-induced transgene silencing. Finally we showed that genetic inhibition of Bel function led 
to the de novo generation of piRNAs from the transgene region inserted in the genome, suggesting 
a potential piRNA-dependent mechanism that may mediate transgene silencing as Bel function is 
inhibited. Our findings have demonstrated a novel involvement of Bel in regulating transgene 
expression and its loss triggers a transgene silencing mechanism mediated by protein regulators 
implicated in RNA processing, piRNA biogenesis, chromatin remodeling and the microRNA 
pathway.
*Correspondence to: Department of Biological Science, Florida State University, Tallahassee, Florida, USA. TEL: (850) 645-1501; 
FAX: (850) 645-8447. wumin@bio.fsu.edu.
1These authors contributed equally to this work.
2Current Address: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, 
Maryland, USA
3Current Address: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA
4Current Address: Department of Biomedical Sciences, College of Medicine, Florida State University, Tallahassee, Florida, USA
5Current Address: School of Biological Sciences, Institute of Evolutionary Biology, The University of Edinburgh, Edinburgh, 
Scotland
6Current Address: The Center for Genomics and Personalized Medicine, Florida State University, Tallahassee, Florida, USA
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Dev Biol. Author manuscript; available in PMC 2017 April 01.
Published in final edited form as:
Dev Biol. 2016 April 1; 412(1): 57–70. doi:10.1016/j.ydbio.2016.02.014.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Keywords
Belle; transgene silencing; Spindle-E; Mod(mdg4); Dcr-1; piRNAs; miRNA
Introduction
Transgene silencing refers to the activity of various host defense responses that ordinarily 
act on natural foreign or parasitic sequences such as transposable elements (TEs), viroids, 
RNA and DNA viruses, and bacterial DNA. Since transgenes or their transcripts can 
resemble these cellular invaders in a number of ways, they naturally become the targets of 
host protective reactions. There are at least two distinct host defense systems responsible for 
silencing transgenes (Fagard and Vaucheret, 2000). One performs its effect via de novo DNA 
methylation at the genome level. The second defense system operates post-transcriptionally 
to silence transgenes, which involves sequence-specific RNA degradation in the cytoplasm. 
Therefore, transgene silencing involves complex cell immune systems including epigenetic 
and RNA silencing mechanisms (Fagard and Vaucheret, 2000). Although many factors 
involved in transgene silencing have been identified, and several mechanisms have been 
proposed, there remains much to understand regarding this vital aspect of the cell immune 
system.
Drosophila oogenesis, which involves the generation of the female gamete (oocyte), nurse 
cells, and follicle cells, is an excellent system for the study of TE and transgene silencing. 
The egg chamber, the developmental unit of oogenesis, contains the germline cells (one 
oocyte and 15 nurse cells) and a layer of surrounding somatically derived epithelial follicle 
cells. Both the germline cells and follicle cells can produce small RNAs to silence TE 
expression (Siomi et al., 2011). The nuage, a perinuclear structure within Drosophila nurse 
cells, is an RNA-rich organelle unique to the germline. The nuage is required for the 
processing and localization of germline mRNAs and for the biogenesis of PIWI-interacting 
RNAs (piRNAs), a class of small non-coding RNAs that function as the cell immune system 
for silencing TEs (Lasko, 2013; Siomi et al., 2011). In D. melanogaster, most primary 
piRNAs are produced from discrete pericentromeric and telomeric heterochromatic loci 
(called piRNA clusters) containing damaged repeated TE sequences (Brennecke et al., 2007; 
Ishizu et al., 2012; Siomi et al., 2011). In fly germline cells, an additional step of piRNA 
biogenesis, the ‘ping-pong cycle’ mechanism, is employed to generate the secondary 
piRNAs (Brennecke et al., 2007; Ishizu et al., 2012; Siomi et al., 2011). Multiple factors 
localized in the nuage of germline cells have been discovered to be essential for secondary 
piRNA biogenesis, including Aub, AGO3, Spindle-E (Spn-E), and Vasa, (Handler et al., 
2013; Malone et al., 2009). In follicle cells, piRNAs are only produced from piRNA clusters 
(e.g. flamenco) via PIWI and other related nuclear factors, and there is no secondary piRNA 
biogenesis involved (Halic and Moazed, 2009; Handler et al., 2013; Ishizu et al., 2012). 
Intriguingly, besides piRNA clusters, euchromatic transposon insertion sites have been 
identified as another origin to produce piRNAs and endo-siRNAs (Shpiz et al., 2014). This 
mechanism provides another layer of defense to suppress TE activity and can also serve as a 
way to affect expression of coding genes and microRNA (miRNA) genes adjacent to 
inserted TEs.
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Vasa and Spn-E belong to a family of DEAD-box proteins defined by multiple distinct 
conserved motifs including the D-E-A-D (Asp-Glu-Ala-Asp) motif (Linder et al., 1989). 
Among the identified DEAD-box proteins, one subfamily is highly conserved from yeast to 
human, which includes orthologs in yeast (DED1), Drosophila (Belle (Bel)), Xenopus 
(An3), mice (PL10), and humans (DDX3) (Johnstone et al., 2005). These DEAD-box 
subfamily proteins possess the ATP-dependent RNA helicase activity to unwind double-
stranded RNA and remodel RNA-protein interactions (Fairman et al., 2004; Iost et al., 
1999). Yeast DED1 is a multifunctional protein that functions to regulate multiple stages of 
RNA processing and translation (Berthelot et al., 2004; Hayashi et al., 1996; Jamieson and 
Beggs, 1991; Schafer et al., 2003; Stevens et al., 2002). DED1 has also been shown to play a 
specific role in cell-cycle control (Forbes et al., 1998; Grallert et al., 2000; Liu et al., 2002). 
DDX3, the human homolog of DED1, is known to be involved in modulating multiple 
biological processes, including antiviral innate immunity (Mamiya and Worman, 1999; 
Owsianka and Patel, 1999; You et al., 1999), mitotic chromosome segregation in somatic 
cells (Pek and Kai, 2011), the suppression of spermatogenesis (Foresta et al., 2000; Lahn 
and Page, 1997), G1-S transition of the cell cycle (Chao et al., 2006), epithelial-
mesenchymal transition (EMT) (Botlagunta et al., 2008), a bona fide component of the 
RNAi pathway (Zhou et al., 2008), TNF-related apoptosis (Sun et al., 2008), and WNT 
signaling (Cruciat et al., 2013).
Vasa, a paralog of Bel, is required for the formation and function of nuage to suppress TE 
expression by being involved in the production of piRNAs (Lasko, 2013; Liang et al., 1994; 
Malone et al., 2009). Most recently, Xiol and colleagues reported that Vasa is a key 
component in the piRNA amplifier complex in the nuage and serves as a protein platform to 
recruit Piwi proteins, the Tudor protein Qin/Kumo and antisense piRNA guides in an ATP-
dependent manner for the ping-pong-loop amplification of secondary piRNAs (Xiol et al., 
2014). Bel colocalizes with Vasa in the nuage and at the oocyte posterior during oogenesis, 
and is required for female fertility (Johnstone et al., 2005). Our recent findings have shown 
that loss of bel delays activation of Notch signaling in follicle cells, which in turn leads to 
delayed cell differentiation and defects in the switch from the mitotic cycle to the endocycle 
(Poulton et al., 2011). However, unlike Vasa, the specific roles of Bel in the nuage of 
germline cells, and whether it is involved in piRNA biogenesis, remain unknown.
From our previous studies, we unexpectedly found that the Gal4-driven expression of a 
UASp-Bel:GFP transgene was silenced in bel mutant germline cells. This silencing effect 
was not specific to bel-based transgenes because 13 out of 22 different transgenic lines we 
tested could be silenced in either germline or somatic bel mutant cells, or both. We 
subsequently identified the RNA helicase Spn-E, the epigenetic regulator Modifier of mdg4 
[Mod(mdg4)] and the miRNA biogenesis enzyme Dcr-1 as crucial factors for this bel-related 
transgene silencing. Their abrogation could either partially or completely rescue the 
transgene-silencing phenotype induced by loss of bel. Importantly, our small RNA deep 
sequencing analysis suggests that a piRNA-mediated mechanism is potentially involved in 
Bel-inactivation-induced transgene silencing. Together, our studies genetically link the 
function of Bel to Spn-E, Mod(mdg4), and Dcr-1, and suggest that transgene silencing 
induced by Bel inactivation may involve RNA processing, piRNA, miRNA, and epigenetic 
mechanisms.
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Materials and Methods
Fly stocks and genetics
The following fly stocks were used in this study: FRT82B bel74407 and FRT82B bel47110 
[obtained from the Szeged stock center] (Poulton et al., 2011); belneo30 and belEKE [a gift 
from P. Lasko; belEKE was recombined with FRT82B in our laboratory]; FRT82B belL4740 
[a gift from M. Frolov] (Ambrus and Frolov, 2010); bel6 [a gift from N. Perrimon; bel6 was 
recombined with FRT82B in our laboratory]; belpsg9 [a gift from A. Bashirullah] (Ihry et al., 
2012); hsp83-IVS3-LacZ [a gift from D. Rio] (Roche et al., 1995); Following lines were 
obtained from the Bloomington Stock Center: FRT82B spn-EhlsΔ125, aubQC42, aubHN2, 
2Mat-Gal4 [two maternally expressing Gal4 drivers were recombined together, BL#7062 
and BL#7063], hsp83-MCP:GFP [BL#7280], ci-LacZ [BL#6303]; FRT82B 
mod(mdg4)L3101 [Kyoto stock center, #111048]; FRT82B Dcr-1Q1147X (Poulton et al., 
2011); ptc-Gal4, UAS-GFP; bel-RNAi [BL# 35302]. Homozygous mutant clones were 
generated by mitotic recombination with the FLP-FRT system (Xu and Rubin, 1993). The 
following stock lines were used to generate mutant clones: hsFLP,Stau:GFP;FRT82B 
ubiGFP/TM3,Sb; hsFLP,Stau:GFP;FRT82B arm-lacZ/TM6b; hsFLP;;FRT82B ubi-RFP/
TM6b. Flies were maintained and raised at 25°C. Adult female flies were heat-shocked for 
30 minutes at 37°C. Two to four days after heat shock, the flies were dissected to harvest 
ovaries. The collected ovaries were subjected to immunofluorescence staining. To generate 
the UASp-Bel:GFP transgenic fly, we amplified the bel cDNA (clone: RE28061, DGRC, 
Indiana) using primers: 5- GTGTGGTACCATGAGTAATGCTATTAACC-3, and 5-
GTGTGCGGCCGCTTGAGCCCACCAGTCGG-3. The PCR products were cloned into the 
Kpn-NotI-digested pUASp-GFP vector DNA and the recombinant DNA was used to 
generate transgenic flies (Genetivision, Houston).
Antibodies, immunofluorescence staining and confocal microscopy
Immunocytochemistry was carried out as described previously (Deng et al., 2001). The 
following antibodies were used: rat anti-Vasa (1:300; from Development Studies Hybridoma 
Bank, DSHB), rabbit anti-Aub and rabbit anti-AGO3 (1:1000; a gift from J. Brennecke), 
rabbit anti-β-Galactosidase (1:2000; from MP Biomedicals), and mouse anti-β-Galactosidase 
(1:500; from Promega). Nuclear DNA was stained with DAPI (Invitrogen). Images were 
acquired with a Zeiss LSM-510 confocal microscope and assembled in Adobe Illustrator.
Quantitative RT-PCR analysis
Total RNA from two-day-old Drosophila ovaries was isolated using Trizol Reagent 
(Invitrogen) according to the manufacturer’s instructions and then treated with 2 U/µl of 
DNase I (Ambion) for 30 minutes at 37°C. One microgram of total RNA was reverse-
transcribed in 20 µl of reaction mixture containing Superscript II reverse transcriptase 
(Invitrogen) and oligo (dT)12–18 primer according to the protocol for Superscript II first-
strand cDNA synthesis system. One microliter cDNA (reverse transcribed from 50 ng of 
RNA) was subjected to quantitative real-time PCR (in 25 µl reaction volume) by using 
primers specific to a transposable element or RP49 (primer sequences can be found in 
supplemental Materials and Methods) and cDNA templates were amplified using the 
Platinum SYBR Green qPCR SuperMix UDG kit, according to the manufacturer’s 
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instructions (Invitrogen). PCR conditions are: 95°C for 10 minutes; 40 cycles of 95°C for 30 
seconds, 58°C for 15 seconds, and 68°C for 45 seconds. Real-time PCR was performed 
using the ABI 7500 Thermocycler (Applied Biosystems), and results were analyzed using 
SDS version 2.1 software (Austin Biodiversity Web site gallery). Data analysis was done 
using the 2−ΔΔCT method for relative quantification. Calculated expression values of cDNA 
samples were normalized to RP49.
Small RNA library preparation and analysis
Small RNA libraries were prepared according to instructions for Illumina TrueSeq Small 
RNA sample prep kit with some modifications that pre-annealing of terminator 
oligonucleotides to Drosophila 2S rRNA was performed prior to 5′ adapter ligation and 
reverse transcription for efficiently depleting 2S rRNA sequences (Wickersheim and 
Blumenstiel, 2013). Small RNA libraries were submitted for sequencing using the Illumina 
HiSeq-2500 sequencing system. Bioinformatic analysis of small RNA libraries was 
performed to analyze sequencing reads from small RNA libraries. Briefly, after clipping the 
Illumina 3’-adapter sequence (TGGAATTCTCGGGTGCCAAGGAA CTCCAGTCAC) 
using cutadapt (cutadapt.readthedocs.org/en/latest), the small RNA reads that passed quality 
control through removal of low-complexity or low-quality sequenced reads using sickle 
(github.com/najoshi/sickle), minimal length filter (>22nt) and the removal of rRNAs, 
snoRNAs and tRNAs reads by bowtie (-a --best --strata -v 1 --un) (bowtie-
bio.sourceforge.net/index.shtml) were mapped to the transgene P[LacW] nucleotide 
sequence (-a -v 0 -m 1) by bowtie. Small RNA sequencing data are deposited at Gene 
Expression Omnibus (GEO), accession number GSE65565.
Results
bel loss-of-function mutations induce transgene silencing in germline and somatic cells
Our previous studies have shown that Bel acts together with the miRNA biogenesis pathway 
to regulate the timing of Notch signaling in follicle cells (Poulton et al., 2011). Intriguingly, 
when we attempted to use the germline-specific mat-Gal4 driver to express UASp-Bel:GFP 
in bel74407 germline clones, the expression of Bel:GFP was silenced (Fig 1A). To determine 
whether this silencing effect is specific to mat-Gal4, we then tested act-Gal4 driven UASp-
Bel:GFP in bel74407 clones. Similar to the mat-Gal4 driver, act-Gal4-driven Bel:GFP 
expression was also silenced in bel74407 germline clones (Fig 1B,1D), suggesting this 
silencing is not restricted to a specific Gal4 driver.
To test whether the silencing of Bel:GFP can occur in a different tissue type we examined its 
expression in bel74407 clones in the wing disc. As shown in Fig S1, UASp-Bel:GFP 
expression was also suppressed in bel74407 wing-disc cells, indicating the transgene 
silencing phenotype is not restricted to ovarian cells.
To rule out the possibility that transgene silencing is allele-specific to bel74407, we tested 
four other bel alleles (belneo30, belL4740, belEKE and bel47710) for their ability in silencing 
UASp-Bel:GFP. The hypomorphic belneo30 allele allowed us to create the bel74407/neo30 
trans-heterozygote adults, which exhibited a similar but less penetrant silencing phenotype 
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of act-Gal4/UASp-Bel:GFP in both the nurse cells (22%, n = 45 germline cells) and the 
follicle cells (63%, n = 332 follicle cells) (Fig 1C), whereas the bel74407/+ heterozygote cells 
did not show the silencing phenotype (Fig 1D). The belL4740 germline clones also 
manifested the silencing phenotype (40%, n = 40) (Fig 1E), but it was not as penetrant as the 
bel74407 homozygous cells. In addition, belEKE and bel47710 homozygous cells showed 
silencing for UASp-Bel:GFP expression in both the germline and follicle cell clones during 
oogenesis (data not shown). These findings, taken together, indicate that the transgene 
silencing phenotype is caused by loss of bel function and is not related to a specific allele, 
nor is it specific to germline or somatic cells.
To determine whether the silencing effect is applicable to other transgenes, we examined 22 
different transgenic lines in bel mutant cells (Table S1). Expression of 13 out of 22 transgene 
lines was silenced in germline and/or somatic bel74407 mutant clones (Table S1). Examples 
of additional transgene silencing included ptc>GFP (ptc-Gal4, UAS-GFP) and ci:LacZ (an 
enhancer trap line) (Fig 1F, G). Therefore, abrogation of bel function likely has a general 
effect to silence expression of many, but not all, transgenes.
Loss-of-bel induced transgene silencing is attributable to downregulation of transgene 
RNA levels
Among the silenced transgenes (Table S1), we were particularly interested in hsp83-IVS3-
LacZ (IVS3-LacZ), a transgene with the intron 3 portion of the P element inserted between 
the hsp83 promoter and the LacZ reporter (Fig 2A), which exhibits germline specific 
expression of β-Galactosidase (Roche et al., 1995). Both bel74407 and bel47110 germline 
clones displayed 100% penetrance for silencing of IVS3-LacZ expression (Fig 2B, C). In 
germline clones of three other bel alleles, bel6, belL4740 and belEKE (Ambrus and Frolov, 
2010; Ihry et al., 2012; Johnstone et al., 2005), IVS3-lacZ was silenced in 56%, 47% and 
70% of the mutant clones, respectively (Fig 2D, E, F). The trans-heterozygote bel74407/neo30, 
on the other hand, showed a partial silencing phenotype, i.e. IVS3-lacZ was silenced in some 
nurse cells, while other nurse cells in the same egg chamber still had IVS3-lacZ expression 
(64%, n = 44 germline cells). In contrast, the heterozygous bel74407/+ showed no silencing of 
the reporter gene expression (Fig 3A, B). These results revealed that multiple bel mutant 
alleles silenced IVS3-LacZ expression. Interestingly, we found that belpsg9, an EMS-induced 
missense mutation (F469S) in the RNA helicase domain of the bel gene (Ihry et al., 2012), 
was unable to cause IVS3-LacZ silencing in germline cells when trans-heterozygous with 
belneo30 (Fig 3C). belpsg9 has been reported to affect the translational function of Bel (Ihry 
et al., 2012), indicating the silencing effect is unlikely related to the regulation of translation.
IVS3-lacZ expression is regulated at both the transcriptional and RNA splicing level. The 
intron 3 of the P element is only spliced out in germline cells, however, its transcription can 
be silenced in ovaries of the progeny from crosses of the M-cytotype males with the P-
cytotype females (Roche et al., 1995). Previously, this transgene line has been exploited to 
study the TE silencing mechanism underlying silencing of P element expression in germline 
cells (Roche et al., 1995). Since DDX3, the human homolog of Bel, has been reported to be 
involved in splicing regulation (Tarn and Chang, 2009), we asked whether IVS-lacZ 
silencing is regulated at the transcriptional level or at the splicing level. To this end, we first 
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performed quantitative RT-PCR (qRT-PCR) analysis on RNA samples isolated from ovaries 
of IVS3-LacZ transgenic flies in the wild-type or trans-heterozygous bel74407/neo30 
backgrounds. We employed a pair of primers complementary to the nuclear localization 
sequence (NLS) and N-terminal β-galactosidase coding sequence (Roche et al., 1995) to 
amplify cDNA generated from both spliced and un-spliced RNAs, respectively (Fig 2A). As 
shown in Fig 4A, overall expressed RNAs from the hsp83-IVS3-LacZ transgene were 
significantly decreased in the bel74407/neo30 sample compared with the wild-type control. 
Consistent with the data from bel mutant ovaries, germline knockdown of Bel, using mat-
Gal4-driven Bel RNAi, also led to reduced RNA levels from hsp83-IVS3-LacZ (Fig 4C). 
These results indicate that silencing of the hsp83-IVS3-LacZ reporter activity in bel mutant 
cells is mainly caused by a significant reduction in its overall RNA levels.
To determine whether the splicing of the intron IVS3 is affected in bel mutant cells, we then 
performed traditional RT-PCR. If germline silencing of hsp83-IVS3-LacZ expression is 
caused by a defect in splicing of the IVS3 intron in bel mutants, we predicted no expression 
or very low levels of spliced IVS3-LacZ transcripts to be detected when compared with 
those of un-spliced transcripts. DNA gel electrophoresis showed that the ratio of spliced 
DNAs to un-spliced DNAs was not significantly affected in bel74407/neo30 ovaries compared 
with the wild-type control (Fig S1B), implying that silencing of hsp83-IVS3-LacZ 
expression in bel74407/neo30 mutant germline cells is unlikely due to a defect in splicing of 
IVS3.
The IVS3-LacZ transgene expression is driven by the hsp83 promoter (Roche et al., 1995), 
we asked whether hsp83-IVS3-LacZ transgene silencing is related to the promoter activity 
of hsp83 in bel mutants. Thus we tested the expression of an unrelated hsp83 promoter-
dependent transgene, hsp83MCP:GFP (GFP-tagged bacteriophage MS2 coat protein) 
(Jaramillo et al., 2008), in bel74407 clones. Interestingly, this transgene showed expression in 
both the germline and follicle cells in the ovary (Fig 4D). As shown in Fig 4D, expression of 
hsp83-MCP:GFP was silenced in both bel74407 germline and somatic follicle cell clones. 
This result implies that silencing of the hsp83-IVS3-LacZ transgene in bel mutants (Fig 2B) 
may be attributable to the suppression of the hsp83 promoter activity. These results, taken 
together, imply that silencing of transgene expression in bel mutant germline cells results 
from a decrease in transgene mRNA levels. Such changes might result from a decrease in 
promoter activity, an increase in the turnover rate of expressed transgene RNAs, or both 
mechanisms.
Spindle-E, Mod(mdg4) and Dcr-1 are involved in bel-mutation-induced transgene silencing
Bel has been shown previously to be involved in siRNA and miRNA function (Pek and Kai, 
2011; Poulton et al., 2011) and TE and transgene silencing is known to be mediated by 
piRNAs and epigenetic regulation (Fagard and Vaucheret, 2000; Siomi et al., 2011). To 
understand the mechanisms underlying transgene silencing induced by bel mutations, we 
asked whether disrupting any of the small RNA silencing pathways would ameliorate the 
silencing effect on IVS3-LacZ or other transgene expression in bel mutants. Specifically, we 
tested several genes (spn-E, mod(mdg4), scm, su(Hw), Dcr-1, Dcr-2, R2D2, su(var)205, 
su(var)3–9) involved in epigenetic regulation or biogenesis of piRNAs, endo-siRNAs or 
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miRNAs, to determine whether any of them genetically interact with bel to regulate 
transgene expression.
Among the genes we examined, we found that disruption of spn-E, a gene required in 
germline cells for piRNA biogenesis (Handler et al., 2013; Malone et al., 2009), was capable 
of alleviating IVS3-LacZ silencing in bel mutants. To examine the role of Spn-E in bel 
mutant transgene silencing, we recombined the spn-EhlsΔ125 mutant allele (Gonzalez-Reyes 
et al., 1997) onto the FRT82B bel74407 chromosome, which enabled us to generate mutant 
clones double homozygous for bel and spn-E. The expression of hsp83-IVS3-LacZ and 
hsp83-MCP:GFP transgenes was clearly detected in these double homozygous germline 
clones (Fig 5A, B). These results suggest that the spn-E mutation alleviates the silencing of 
either transgene in homozygous bel74407 cells (Fig 2B, 4D), and that Spn-E is required for 
transgene silencing elicited by bel abrogation. Since bel mutant cells also showed transgene 
silencing in somatic follicle cells, we then examined the effect of Spn-E on the expression of 
the ptc-Gal4>UAS-GFP in bel mutant follicle cell clones. Similarly, abrogation of Spn-E 
function also alleviated the silencing effect and restored GFP expression in bel74407 follicle 
cell clones (Fig 5C). These findings together indicate that Spn-E function is necessary for 
transgene silencing in bel-mutant- germline and somatic cells.
In addition to spn-E, we found that the mod(mdg4)L3101 allele was able to alleviate the 
silencing of IVS3-LacZ in bel mutant germline clones (Fig 5D). The restoration of transgene 
expression was recapitulated when hsp83-MCP:GFP expression was examined in both the 
germline and follicle-cell clones carrying double mutation for mod(mdg4)L3101 and bel74407 
(Fig 5E, F). The Mod(mdg4) proteins are involved in position effect variegation (PEV) and 
modifying the properties of insulators, the chromatin regulatory elements influencing gene 
expression (Buchner et al., 2000; Golovnin et al., 2014). Therefore, our results suggest that 
epigenetic events mediated by Mod(mdg4) are involved in transgene silencing induced by 
loss of bel function.
The miRNA biogenesis enzyme Dicer-1 (Dcr-1) was also found to be involved in bel-
mutation-induced transgene silencing. In germline clones double mutant for bel74407 and 
Dcr-1Q1147X (Lee et al., 2004), the expression of IVS3-LacZ was restored (Fig 5G). 
Although Dcr-1Q1147X also restored the germline expression of hsp83-MCP:GFP silenced 
by bel74407, it had no effect on silencing of hsp83-MCP:GFP in bel mutant follicle cell 
clones (Fig 5H), suggesting a different mechanism may exist between the germline cells and 
the somatic cells in bel−/− induced transgene silencing. In conclusion, these findings 
genetically link Bel to the piRNA-related RNA helicase Spn-E, the chromatin modulator 
Mod(mdg4) and the Dcr-1 enzyme involved in miRNA biosynthesis.
bel, spn-E double mutants show normal localization of nuage protein components
Bel and Spn-E are known to colocalize at the nuage of germline nurse cells (Handler et al., 
2013; Johnstone et al., 2005). Some of the nuage protein components have been reported to 
be required for maintaining the subcellular localization of other nuage protein components 
that are functionally associated with them (Findley et al., 2003; Handler et al., 2013; Lim 
and Kai, 2007; Malone et al., 2009). Mutations in spn-E have been shown to disrupt the 
nuage localization of piRNA-related proteins such as Aub and Maelstrom (Mael), but only 
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moderately affect the particulate appearance of Vasa in the nuage (Findley et al., 2003; Lim 
and Kai, 2007). This effect from Spn-E is consistent with the crucial role of Spn-E in 
germline piRNA biogenesis (Malone et al., 2009). To determine whether loss of bel affects 
nuage localization of piRNA-related protein components, we examined the localization of 
Aub and AGO3, two PIWI subfamily proteins that act as ping-pong factors crucial for 
secondary piRNA biogenesis (Brennecke et al., 2007; Handler et al., 2013; Malone et al., 
2009), and Vasa in bel germline clones. Loss of bel, however, had no significant effect on the 
nuage localization of Vasa, Aub and AGO3 (Fig 6A,B). In contrast, spn- EhlsΔ125 germline 
clones showed loss and/or mislocalization of Aub and partial mislocalization of AGO3 and 
Vasa proteins from the nuage (Fig 6C). The spn-EhlsΔ125 germline clones manifested a 
stronger Vasa mislocalization phenotype compared with previous reports using 
transheterozygous spn-E mutants (spn-E616/hls3987 and spn-E616/hlsΔ125) (Findley et al., 
2003; Lim and Kai, 2007). Surprisingly, we found that in germline clones double mutant for 
spn-E and bel, the nuage localization of all three proteins was restored (Fig 6D), suggesting 
that Bel is involved in the mislocalization of nuage protein components when Spn-E is 
absent.
Inhibition of Bel function leads to the de novo generation of piRNAs from the transgene 
inserted in the genome
The recent findings from Olovnikov and colleagues have shown that piRNAs can be 
generated directly from the transposon-derived transgene area located in the euchromatic 
genome (Olovnikov et al., 2013). Given that piRNAs are known to silence TEs and protein-
coding genes at both the transcriptional and post-transcriptional level, their findings suggest 
that piRNA-mediated silencing mechanism is potentially involved in transgene silencing. To 
explore whether Bel-dependent transgene silencing is related to this mechanism, we isolated 
small RNAs from wild-type (w1118) and trans-heterozygous bel74407/neo30 ovaries and 
performed small RNA deep sequencing analysis. We examined piRNA reads mapped to the 
inserted transgene sequence, P[LacW], which was exploited to create the mutated allele 
bel74407. As shown in Fig 7, a significant number of piRNA reads (normalized mapped read 
count 215 ± 7, n = 3, p < 0.05) derived from bel74407/neo30 mutant ovaries were mapped to 
P[LacW], whereas only a very low number of background piRNAs (16 ± 3, n = 3) derived 
from control wild-type ovaries were mapped to P[LacW]. This finding indicates that Bel 
inhibition results in the de novo generation of piRNAs from the inserted transgene region in 
the genome.
Discussion
In this article, we report that loss-of-bel function triggers transgene silencing, which occurs 
through reduction in transgene RNA levels. Furthermore, our genetic studies indicate that 
this transgene silencing effect induced by bel abrogation requires the RNA helicase Spn-E, 
the insulator modulator Mod(mdg4) and/or the miRNA biosynthesis enzyme Dcr-1. Based 
on the functional roles of these three molecules, our data suggest that this transgene 
silencing effect may involve RNA processing, chromatin remodeling and/or miRNA 
biogenesis. This transgene silencing event occurring under various bel mutant backgrounds 
implies that Bel may regulate these three molecular mechanisms to sustain transgene 
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expression in the normal physiological condition. Intriguingly, our studies also identified 
additional complexity in the relationship between Bel and Spn-E because the mislocalization 
of nuage components in spn-E mutants requires Bel. Therefore, our findings, taken together, 
provide new insight into Bel function and expand the molecular interaction network 
radiating from Bel.
Our studies show that loss of bel gave rise to transgene silencing via decreased transgene 
RNA levels. This phenomenon could be attributable to either transcriptional suppression or 
increased RNA degradation. Some support for an RNA degradation/targeting mechanism 
comes from our finding that Spn-E is required for transgene silencing induced by loss of bel. 
In germline nurse cells, Spn-E, which is located in the cytoplasmic nuage, is crucial for 
properly maintaining the subcellular localization of piRNA-related protein factors in the 
nuage, the ping-pong reaction of piRNA biogenesis, and silencing of TEs (Handler et al., 
2013; Malone et al., 2009). Spn-E is also required for the proper localization of RNA 
transcripts (e.g., Bicoid and Oskar) during oogenesis, which might be related to its role in 
organizing a cytoskeletal framework (Gillespie and Berg, 1995). Therefore, it is plausible 
that the Spn-E-dependent RNA processing activity and/or Spn-E-generated piRNAs mediate 
transgene RNA degradation. In addition, it is possible that piRNAs can also elicit 
transcriptional silencing of transgenes based on their nuclear epigenetic role in TE silencing. 
Another striking finding from our studies shows that Bel is involved in disrupting the 
subcellular localization of nuage components when Spn-E is abrogated. In contrast, loss of 
Bel alone had no impact on the localization of piRNA-related nuage protein components. 
These findings suggest that there could be a competitive relationship between Bel and Spn-
E, where these two molecules negatively regulate each other. This hypothesis is also 
supported by our observations that Spn-E is required for transgene silencing when Bel is 
abrogated. According to these findings, we envisage a model that Bel may function as a 
negative regulator for ping-pong-cycle-mediated piRNA biogenesis via disrupting the nuage 
localization of piRNA-related proteins as Spn-E function is abrogated, whereas Spn-E may 
be aberrantly activated by loss of Bel, in turn leading to transgene silencing. Whether 
piRNAs generated from the Spn-E-mediated ping-pong cycle are involved in transgene 
silencing is currently unknown. However, a recent study has shown that piRNAs can be 
generated directly from the transposon-derived transgene insertion area located in the 
euchromatic genome, which have been proposed to be involved in transgene silencing 
(Olovnikov et al., 2013). This finding links piRNAs to transgene silencing. Our preliminary 
small RNA deep sequencing analysis showed that the viable trans-heterozygous 
bel74407/neo30 mutant ovaries, which manifest a partial transgene silencing phenotype, 
displayed no significant defect in overall piRNA biogenesis from piRNA clusters and the 
ping-pong cycle, indicating that unlike Vasa, Bel is not involved in regulating piRNA 
generation (data not shown). This finding is consistent with the result that homozygous bel 
mutants had no defect in nuage protein localization (Fig 6), which is different from other 
piRNA-related nuage proteins whose defects can significantly disturb the localization of 
other nuage protein components (Findley et al., 2003; Handler et al., 2013; Lasko, 2013; 
Lim and Kai, 2007; Malone et al., 2009). Nevertheless, our deep sequencing analysis also 
identified de novo piRNAs generated in bel74407/neo30 mutant ovaries (but not in wild-type 
ovaries) that could be mapped to the integrated P-element-derived transgene sequence area 
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(P[LacW]). This result is in line with Olovnikov’s findings (Olovnikov et al., 2013) and 
indicates that the de novo generation of piRNAs from the inserted transgene region in the 
genome occurs under the bel mutant background. Given that Bel is a paralog of Vasa and our 
genetic findings also suggest a competitive relationship between Bel and Spn-E, loss of Bel 
may disrupt its normal regulation of some small RNA-related helicases and co-factors, 
which in turn aberrantly activates the small RNA pathway(s). Therefore, it is possible that 
loss of Bel may promote de novo piRNA biogenesis from the transgene insertion sites by 
freeing these small RNA regulators and provoking the activation of their related small RNA 
pathway(s), which is one possible mechanism leading to transgene silencing. Since we were 
unable to create viable mutant progeny bearing mutations at both bel and spn-E gene loci, it 
is still uncertain whether Spn-E is involved in regulating de novo piRNA biogenesis from 
transgene insertion sites. Although we could not elucidate the detailed mechanism due to 
technical hurdles, exploring the regulatory roles of Bel and Spn-E in this new type of piRNA 
biogenesis will be key, interesting research for understanding molecular mechanisms 
underlying transgene silencing.
Another unexpected finding is that the spn-E mutant rescue of transgene silencing associated 
with loss of bel also occurs in somatic follicle cells. This indicates that in addition to its 
well-known function in germline cells, Spn-E may have a somatic function. As Spn-E is not 
implicated in somatic piRNA biogenesis (e.g., flamenco) (Handler et al., 2013; Malone et 
al., 2009), it is uncertain how Spn-E mediates somatic transgene silencing and whether 
piRNAs participate in this event. Therefore, it will be important in the future to unravel 
whether the mechanism by which Spn-E facilitates transgene silencing in bel mutant somatic 
cells is the same as that in germline cells.
The common feature for transgenes silenced by Bel abrogation is their P-element-based 
integration into genomic DNA. The observation that some P-element-based transgenes were 
not silenced in bel mutant cells raises an interesting question about what factors can 
determine whether a transgene can be silenced or not. From genetic analysis of a series of 
transgenes (n = 22) (Table S1), we observed that six examined transgenes (ci-LacZ, dMyc-
LacZ, dom-LacZ, C306-Gal4, ptc-Gal4, Tj-Gal4), which were generated by the insertion of 
two different P-element-derived vector sequences (P[LacW] and P[GawB]), were silenced 
under the bel mutant background. In contrast, two transgenes (histone-GFP, histone-RFP) 
generated by the insertion of P[His2Av]-derived vector sequences were not silenced by Bel 
inactivation. Although these data are not a conclusive result, they imply that the inserted 
transgene sequence itself, not the insertion location in the genome, may be a critical 
determinant for Bel-dependent transgene silencing since this silencing phenotype seems to 
be transgene-specific and a change in the transgene insertion location in the genome has no 
influence on whether this transgene can be silenced or not when Bel function is inhibited. It 
is possible that the transgene sequence determines a local chromosomal conformation and 
whether the transgene can be silenced under the bel mutant background is determined by 
whether its chromosomal structure can be recognized by epigenetic regulators involved in 
transgene silencing. Although further investigations are still needed to verify this hypothesis 
due to limited cases in our study, it raises the possibility that epigenetic regulation at the 
chromatin level may be involved in Bel-dependent transgene silencing. Indeed, besides Spn-
E, our genetic study identified Mod(mdg4) as another crucial factor required for transgene 
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silencing in both germline and somatic cells when Bel is abrogated. The mod(mdg4) gene 
encodes multiple nuclear factors through trans-splicing and this protein family is 
functionally involved in the modification of the properties of insulators, which are genomic 
elements that regulate gene expression (Buchner et al., 2000; Golovnin et al., 2014). 
Mod(mdg4) proteins can function as chromatin modulators engaged in the organization of 
highly ordered chromatin domains (Buchner et al., 2000; Golovnin et al., 2014). The 
involvement of Mod(mdg4) in transgene silencing suggests that nuclear epigenetic events 
are also crucial for induction of transgene silencing when Bel is inactivated. However, the 
role of Mod(mdg4) in transgene silencing might also be indirect, such as through its 
regulation of other genes that could contribute to silencing. Nevertheless, our findings 
suggest that the coordination between nuclear and cytoplasmic events mediated by 
Mod(mdg4) and Spn-E, respectively, is mandatory for induction of transgene silencing when 
Bel is functionally inhibited.
The miRNA biogenesis enzyme Dcr-1 (Lee et al., 2004) is the third factor identified from 
our studies that is crucial for transgene silencing in the absence of Bel. Interestingly, the 
block in transgene silencing in this case (double mutant for bel and dcr-1) only occurred in 
germline cells, but not in somatic cells. This discovery raises the possibility that there are 
additional miRNA-targeted proteins present in germline cells, but not in somatic cells, and 
they can interact with factors essential for germline transgene silencing. If this is a case, 
aberrantly elevated levels of these miRNA-targeted proteins in Dcr-1 mutant germline cells 
might interfere with transgene silencing. Besides this possible indirect role, another 
possibility is that the Dcr-1-dependent miRNA pathway may play a direct role in transgene 
silencing in germline cells as Bel is abrogated. The miRNA pathway has been shown to be 
implicated in transgene silencing in Drosophila S2 cells (Siomi et al., 2005). Although the 
silencing mechanism is unclear, this finding raises a possible direct role of the Dcr-1-
dependent miRNA pathway in bel-mutant transgene silencing. A study from Zhou and 
colleagues has shown that Bel proteins were cofractionated with the miRNA-dependent 
RNA-induced silencing complexes (miRISCs) and co-immunoprecipitated with Ago1, the 
protein component of miRISCs (Zhou et al., 2008). This finding suggests a compelling 
possibility that Bel may be directly involved in the miRNA pathway to regulate miRISC-
dependent RNA silencing and Bel inactivation may result in the aberrant functionality of 
miRISC and its related RNA silencing. Since miRNAs can target mRNAs via their short 
seed sequences, a possibility which cannot be ruled out is that some miRNAs may directly 
target transngene RNAs to regulate their levels. Future investigation is needed to reveal 
which possibility is more relevant.
In conclusion, our findings provide novel insights into the regulatory role of Bel in the 
expression of transgenes in Drosophila and its functional linkage to crucial factors 
implicated in RNA processing, chromatin remodeling and miRNA biogenesis. These 
findings further advance our understanding of the complex cellular functions of Bel. Our 
studies of the role for Bel in transgene expression may have important, future implications 
for understanding the regulation of expression of newly invaded or transposed TEs (Shpiz et 
al., 2014) and virus-retrotransposon DNA chimeras generated from viral infection (Goic et 
al., 2013) as they may share the similar scenario as transgene integration.
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Highlights
• Loss of Belle (Bel), a DEAD-box RNA helicase, induces transgene silencing.
• Spindle-E, Mod(mdg4) and Dcr-1 mediate transgene silencing in bel mutants.
• The balance between Spindle-E and Bel is vital to sustain the nuage integrity.
• Inhibition of Bel leads to the de novo generation of piRNAs from the transgene.
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Figure 1. Expression of transgenes in germline and somatic cells is silenced in bel mutants
(A, A', A") Expression of Bel:GFP driven by germline-specific mat-Gal4 is silenced in 
bel74407 homozygous mutant germline cell clones. Egg chamber were stained with anti-β-
galactosidase antibody (red in A, white in A'). Expression of Bel:GFP is indicated by the 
green fluorescence from GFP (green in A, A"). bel74407 mutant germline cell clones (β-
galactosidase-negative) are indicated by asterisks. (B, B', B") Expression of Bel: GFP driven 
by act-Gal4 is silenced in bel74407 mutant germline cell clones. bel74407 homozygous mutant 
germline cell clones are identified by the absence of RFP (red in B, white in B'). Expression 
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of Bel: GFP is indicated by the green fluorescence from GFP (green in B"). (C, C') Random 
silencing of Bel: GFP expression driven by the act-Gal4 driver in trans-heterozygous 
bel74407/neo30 mutant germline (indicated by asterisks) and somatic follicle (outlined) cells 
of egg chambers. Bel:GFP expression is indicated by the GFP fluorescence (green in C, C'). 
(D) Normal act>Bel:GFP expression in wild-type germline and somatic follicle cells of egg 
chambers. (E, E', E") Silencing of Bel: GFP expression driven by mat-Gal4 in belL4740 
mutant germline cell clones. belL4740 homozygous mutant germline cell clones (indicated by 
an asterisk) are identifiable by the absence of β-galactosidase staining (red in E, white in E'). 
Bel:GFP expression is indicated by the GFP green fluorescence (green in E, E"). (F, F, F") 
Expression of UAS-GFP driven by ptc-Gal4 is silenced in bel74407 mutant follicle cell 
clones. The GFP fluorescence indicating UAS-GFP expression is in green (F) or in white 
(F"). The follicle cell clones homozygous for bel74407 lack RFP (outlined) and wild-type 
cells are RFP-positive (red in F, white in F'). (G, G', G") Expression of ci:LacZ (ci:LZ) is 
silenced in bel74407 mutant follicle cell clones. β-galactosidase staining is in green (G) or in 
white (G"). bel74407 homozygous mutant follicle cell clones are identifiable by the absence 
(outlined) of RFP (red in G, white in G'). DAPI (in blue) was used to stain nuclear DNA. 
The orientation of egg chambers in confocal images is anterior (left) to posterior (right). The 
scar bar indicates 10 µm.
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Figure 2. Different bel mutations trigger various degrees of transgene silencing
(A) A diagram showing the structure of the transgene hsp83-IVS3-LacZ. The left and right 
red lines shown in the diagram indicate the DNA sequence areas used to design forward and 
reverse primers, respectively, for quantitative RT-PCR analysis. Egg chambers of female 
progeny from the crosses of the IVS3-LacZ fly line with various bel mutant fly lines were 
stained with anti-β-galactosidase antibody and DAPI (blue inB, C, D, E, F) to label nuclear 
DNA. Germline cell clones homozygous for bel mutant alleles (marked by asterisks) are 
identifiable by the absence of GFP (green in B, C, D, E, F; white in B', C', D', E', F'). 
Expression of IVS3-LacZ is indicated in red (B, C, D, E, F) or in white (B", C", D", E", F"). 
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(B- B") Expression of the transgene IVS3-LacZ is silenced in bel74407 mutant germline 
cells. (C- C") Expression of IVS3-LacZ is silenced in bel47110 mutant germline cells. (D- 
D") Expression of IVS3-LacZ is silenced to various degrees in different bel6 mutant 
germline cell clones. (E- E") Expression of IVS3-LacZ is partially silenced in belL4740 
homozygous mutant germline cell clones. (F- F") Expression of IVS3-LacZ is partially 
silenced in homozygous belEKE mutant germline cell clones. The orientation of egg 
chambers in confocal images is anterior (left) to posterior (right). The scar bar indicates 10 
µm.
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Figure 3. The belpsg9 mutation fails to exhibit the transgene silencing phenotype in the trans-
heterozygote with the hypomorphic belneo30 mutation
Egg chambers of ovaries carrying bel mutations and the IVS3-LacZ transgene were stained 
with anti-β-galactosidase antibody (white in A', B', C') and DAPI (blue in A, B, C) to label 
nuclear DNA. (A, A') Heterozygous bel74407/+ mutant egg chambers exhibit no silencing of 
IVS3-LacZ. (B, B') Trans-heterozygous bel74407/neo30 mutant egg chambers exhibit partial 
silencing of IVS3-LacZ. (C, C') Trans-heterozygous bepsg9/neo30 mutant egg chambers 
exhibit no silencing of IVS3-LacZ. The orientation of egg chambers in confocal images is 
anterior (left) to posterior (right). The scar bar indicates 10 µm.
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Figure 4. Bel inactivation induces a reduction in transgene RNA levels
(A) Overall RNA expression from the transgene IVS3-LacZ is dramatically reduced in trans-
heterozygous bel74407/neo30 mutant ovaries Quantitative RT-PCR was performed on total 
RNA isolated from ovaries of trans-heterozygous bel74407/neo30 mutant flies using primers 
indicated in (Fig 2A) as described in “Materials and Methods”. Triplicate experiments were 
performed for qRT-PCR analysis. Error bars indicate standard deviations and a decrease in 
hsp83-IVS3-LacZ expression in bel mutant ovaries is statistically significant (p < 0.05) 
compared with the control ovaries. (B) Expression of the transgene hsp83-MCP:GFP is 
silenced in bel74407 mutant germline (the top panel) and somatic follicle (the bottom panel) 
cell clones. Homozygous bel74407 mutant germline (indicated by an asterisk) and somatic 
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follicle (outlined) cell clones are identifiable by the absence of RFP (red in the left panel, 
white in the middle panel). The GFP fluorescence to indicate expression of hsp83-MCP:GFP 
is in green (the left panel) or in white (the right panel). DAPI staining to label nuclear DNA 
is in blue. The scar bar indicates 10 µm. (C) Germline-specific knockdown of Bel by RNAi 
leads to downregulation of RNA expression from hsp83-IVS3-LacZ. The Bel RNAi 
expression was driven by the germline-specific mat-Gal4 driver. The control is the fly line 
only carrying mat-Gal4 without UAS-bel-RNAi.
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Figure 5. The RNA helicase Spn-E, insulator modifier Mod(mdg4) and endoribonuclease for 
miRNA biogenesis Dcr-1 are required for transgene silencing induced by Bel abrogation
(A, B, C) Inactivation of Spindle-E by a mutation rescues the transgene silencing phenotype 
exhibited in bel mutant germline and somatic cells. In (A, A', A"), the double mutant 
germline cell clones homozygous for bel74407 and spn-EhlsΔ125 (indicated by an asterisk) are 
identified by the absence of GFP (green in A, white in A'), and expression of hsp83-IVS3-
LacZ was detected by staining with anti-β-galactosidase antibody (red in A, white in A"). In 
(B, B', B"), the double mutant germline cell clones homozygous for bel74407 and spn-
EhlsΔ125 (indicated by an asterisk) are identifiable by the absence of RFP (red in B, white in 
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B') and the expression of hsp83-MCP:GFP is indicated by the GFP fluorescence shown in 
green (B) or in white (B"). In (C, C', C"), the double mutant follicle cell clones homozygous 
for bel74407 and spn-EhlsΔ125(outlined) are detected by the absence of RFP (red in C, white 
in C') and the expression of ptc>GFP is identified by the GFP fluorescence shown in green 
(C) or in white (C"). (D, E, F) The mod(mdg4) mutation suppresses the transgene silencing 
in germline and somatic cells triggered by Bel abrogation. In (D, D', D"), the double mutant 
germline cell clones homozygous for bel74407 and mod(mdg4)L3101 (indicated by an 
asterisk) are identified by the absence of GFP (green in D, white in D'), and immunostaining 
of β-galactosidase expressed from hsp83-IVS3-LacZ is shown in red (D) or in white (D"). In 
(E, E', E"), the double mutant germline cell clones homozygous for bel74407 and 
mod(mdg4)L3101 are identifiable by the absence of RFP (red in E, white in E') and the 
expression of hsp83-MCP:GFP is indicated by the GFP fluorescence shown in green (E) or 
in white (E"). In (F, F', F"), the double mutant follicle cell clones homozygous for bel74407 
and mod(mdg4)L3101 (outlined) are detected by the absence of RFP (red in F, white in F') 
and the expression of hsp83-MCP:GFP is identified by the GFP fluorescence shown in green 
(F) or in white (F"). (G, H) Transgene silencing induced by Bel inactivation is partially 
rescued by mutation-mediated inhibition of the Dcr-1 gene in germline cells, but not in 
somatic follicle cells. In (G, G', G"), the double mutant germline cell clones homozygous for 
bel74407 and Dcr-1Q1147X are identifiable by the absence of GFP (green in G, white in G'), 
and β-galactosidase staining to indicate hsp83-IVS3-LacZ expression is shown in red (G) or 
in white (G"). In (H, H', H"), the double mutant germline and somatic follicle (outlined) cell 
clones homozygous for bel74407 and Dcr-1Q1147X are identifiable by the absence of RFP (red 
in H, white in H'), and the GFP fluorescence indicating the expression of hsp83-MCP:GFP 
in germline and somatic follicle cells is shown in green (H) or in white (H""). DAPI (in blue) 
was used to stain nuclear DNA. The orientation of egg chambers in confocal images is 
anterior (left) to posterior (right). The scar bar indicates 10 µm.
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Figure 6. Inactivation of Bel rescues the phenotype of mislocalization of nuage components in 
spn-E mutant germline nurse cells
Immunofluorescent staining was performed to detect the subcellular localization of Aub (A, 
B, C, D), AGO3 (A', B', C', D') and Vasa (A", B", C", D") in wild-type (wt) (A, A', A"), 
bel74407 mutant (bel−) (B, B', B"), spn-EhlsΔ125 mutant (spn-E−) (C, C', C") and bel− +spn-
E− double mutant (D, D', D") germline nurse cell clones of egg chambers. Aberrant 
localization of protein staining is indicated by a yellow arrow. The scar bar indicates 10 µm.
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Figure 7. Mapping of sequenced reads from piRNAs in wild-type and bel mutant ovaries to the 
transgene P[LacW] sequence
The top panel is the diagram for the sequence composition of the transgene P[LacW] that 
was inserted in the Drosophila genome to create the bel mutant. The two ends (the green 
regions) of P[LacW] are derived from P element. The piRNA sequencing reads (> 22 nt) 
from two ovary samples for each wild-type and bel74407/neo30 mutant were mapped to the 
sequence of P[LacW]. The y axis indicates normalized aligned read counts for sense 
(positive) and antisense (negative) piRNAs.
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